ERSAI
Live / Applied — Statement of use — registration review complete (as of 01 Apr 2026)
What this means for you
Not registered yet, but its 29 Nov 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97145951
- Mark type
- Stylized text
- Filed
- 29 Nov 2021
- Published for opposition
- 18 Jul 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Scientific condensate-based research in the field of drug discovery and drug development; providing online, non-downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery; online, non-downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the field of scientific research and drug discovery
Owner
- Dewpoint Therapeutics, Inc., Boston, MA, US
- Dewpoint Therapeutics, Inc., Boston, MA, US
Prosecution history
- 01 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Aug 2025 — USE AMENDMENT FILED
- 05 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 13 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2025 — SOU EXTENSION 3 GRANTED
- 12 Mar 2025 — SOU EXTENSION 3 FILED
- 12 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2024 — SOU EXTENSION 2 GRANTED
- 10 Sept 2024 — SOU EXTENSION 2 FILED
- 10 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 09 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED